For research use only. Not for therapeutic Use.
Leriglitazone hydrochloride(Cat No.:R045313)is an oral, selective peroxisome proliferator-activated receptor (PPAR) gamma agonist used primarily in the treatment of metabolic and neurodegenerative disorders. By activating PPAR gamma, it regulates genes involved in glucose metabolism, lipid homeostasis, and inflammation. Leriglitazone has shown potential for managing conditions such as Alzheimer’s disease and type 2 diabetes due to its ability to improve insulin sensitivity and reduce neuroinflammation. It is also being studied for its neuroprotective effects, offering promise as a therapeutic option in treating neurodegenerative diseases and metabolic syndromes.
CAS Number | 146062-46-6 |
Synonyms | 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride |
Molecular Formula | C19H21ClN2O4S |
Purity | ≥95% |
IUPAC Name | 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride |
InChI | InChI=1S/C19H20N2O4S.ClH/c1-12(22)14-4-5-15(20-11-14)8-9-25-16-6-2-13(3-7-16)10-17-18(23)21-19(24)26-17;/h2-7,11-12,17,22H,8-10H2,1H3,(H,21,23,24);1H |
InChIKey | SBHOQYCDAHAMDW-UHFFFAOYSA-N |
SMILES | CC(C1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3)O.Cl |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |